Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CytOSorb TreatMent Of Critically Ill PatientS Registry: International Registry on the Use of CytoSorb in the Critical Care Setting

NCT05146336 is registered in ClinicalTrials.gov with CytoSorbents, Inc as lead sponsor.

NCT NCT05146336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05146336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CytOSorb TreatMent Of Critically Ill PatientS Registry: International Registry on the Use of CytoSorb in the Critical Care Setting
Lead sponsor
CytoSorbents, Inc
Phase
Observational
Overall status
Recruiting
Start date
June 22, 2022
Completion date
September 30, 2032
Enrollment
3,000 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

acute liver failure, acute on chronic liver failure, acute respiratory distress syndrome, burns, cardiogenic shock, chimeric antigen receptor t-cell therapy (car-t) cytokine release syndrome (crs), drug overdose, extracorporeal life support, hemophagocytic lymphohistiocytoses, infectious disease, liver transplant; complications, pancreatitis, postoperative endocarditis, postoperative vasoplegic syndrome, rhabdomyolysis, sepsis, septic shock, trauma